OSTRACH MICHAEL S 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Feb 14, 2020
Insider Transaction Report
Form 4
OSTRACH MICHAEL S
VP, CBO, and General Counsel
Transactions
- Exercise/Conversion
Common Stock
2020-02-12+22,000→ 153,604 total - Award
Stock Option (Right to Buy)
2020-02-12+105,000→ 105,000 totalExercise: $5.42Exp: 2027-02-11→ Common Stock (105,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2020-02-12+22,000→ 0 total→ Common Stock (22,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock that vested and converted to common stock on February 12, 2020.
- [F2]This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date, and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter.